Drug Overdose - Pipeline Review, H2 2017

Publisher Name :
Date: 12-Sep-2017
No. of pages: 48
Inquire Before Buying

Drug Overdose - Pipeline Review, H2 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Drug Overdose - Pipeline Review, H2 2017, provides an overview of the Drug Overdose (Toxicology) pipeline landscape.

Drug overdoses occur when a person takes more than the medically recommended dose of a prescription or over-the-counter drug. It can be either accidental or intentional. Symptoms include sleepiness, confusion, chest pain, seizures, abdominal pain, nausea, vomiting, and diarrhea. Risk factors include age, gender, mental illness and history of overdose. Treatment includes antidote and activated charcoal.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Drug Overdose - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Drug Overdose (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Drug Overdose (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Drug Overdose and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 2, 1, 1, 1, 2 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Drug Overdose (Toxicology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Drug Overdose (Toxicology).

- The pipeline guide reviews pipeline therapeutics for Drug Overdose (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Drug Overdose (Toxicology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Drug Overdose (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Drug Overdose (Toxicology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Drug Overdose (Toxicology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Drug Overdose (Toxicology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Drug Overdose - Pipeline Review, H2 2017

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Drug Overdose - Overview
Drug Overdose - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Drug Overdose - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Overdose - Companies Involved in Therapeutics Development
Fab'entech SA
Insys Therapeutics Inc
Klaria Pharma Holding AB
Opiant Pharmaceuticals Inc
Drug Overdose - Drug Profiles
Antibody for Poisoning, Drug Overdose and Opioid Addiction - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FBT-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
melatonin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
naloxone hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
naloxone hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
naloxone hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
naloxone hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
naloxone hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for Drug Overdose - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Vaccine for Drug Overdose - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drug Overdose - Dormant Projects
Drug Overdose - Discontinued Products
Drug Overdose - Product Development Milestones
Featured News & Press Releases
Aug 10, 2017: Opiant Pharmaceuticals Announces Additional $3.75 Million Payment From NARCAN Nasal Spray Royalty Monetization
Aug 04, 2017: Opiant Pharmaceuticals Announces FDA Orange Book Listing for New NARCAN Nasal Spray Patent
Jun 18, 2017: ResQ Pharma Receives FDA Orphan Drug Designation for LipidRescue Therapy for the Treatment of Local Anesthetic Systemic Toxicity
Jun 06, 2017: Survey Data Published on Community Use of NARCAN (naloxone HCI) Nasal Spray 4 mg to Help Reverse Opioid-Related Overdose - Current Medical Research and Opinion Journal
Apr 24, 2017: Emergency opioid treatment NARCAN Nasal Spray added to NIHB Program in Canada
Apr 11, 2017: Ontario ministries make NARCAN Nasal Spray available to general public
Apr 10, 2017: Adapt Pharma Expands Free NARCAN Nasal Spray Program to U.S. Colleges and Universities
Mar 27, 2017: Opiant Pharmaceuticals Announces Results of Positron Emission Tomography Study of Naloxone Nasal Spray
Mar 16, 2017: New Data Presented on Adapt Pharmas Community Use of Narcan Nasal Spray 4 mg to Reverse Opioid-Related Overdose
Mar 15, 2017: Mucodel Pharma Announces Patent Allowance for Mucodel's Co-Gel Buccal Naloxone (Exonal)
Mar 09, 2017: Opiant Pharmaceuticals Announces FDA Orange Book Listings for Two New NARCAN Nasal Spray Patents
Feb 28, 2017: Adapt Pharma Marks One-Year Anniversary of NARCAN Nasal Spray (naloxone HCl) 4mg Launch in the U.S.
Feb 21, 2017: Adapt Pharma Announces European Marketing Application Filed For Naloxone Hydrochloride Nasal Spray
Jan 30, 2017: Kroger Pharmacies to Increase Access to Naloxone in North Texas, East Texas and Southeast Texas
Jan 11, 2017: Opiant Pharmaceuticals Announces 2017 Corporate and Clinical Goals
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Drug Overdose, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Products under Development by Companies, H2 2017
Products under Development by Universities/Institutes, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Drug Overdose - Pipeline by Fab'entech SA, H2 2017
Drug Overdose - Pipeline by Insys Therapeutics Inc, H2 2017
Drug Overdose - Pipeline by Klaria Pharma Holding AB, H2 2017
Drug Overdose - Pipeline by Opiant Pharmaceuticals Inc, H2 2017
Drug Overdose - Dormant Projects, H2 2017
Drug Overdose - Discontinued Products, H2 2017

List of Figures
Number of Products under Development for Drug Overdose, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products by Targets, H2 2017
Number of Products by Stage and Targets, H2 2017
Number of Products by Mechanism of Actions, H2 2017
Number of Products by Stage and Mechanism of Actions, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Molecule Types, H2 2017
Number of Products by Stage and Molecule Types, H2 2017
  • 2017-2022 China Cetirizine Hydrochloride Market Report (Status and Outlook)
    Published: 21-Nov-2017        Price: US 3360 Onwards        Pages: 128
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Cetirizine Hydrochloride market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include - UCB Pharma - Pfizer - J & J - Mylan - Teva - HUAPONT Pharm - Hunan Jiudian Pharm - Sun Pharma - Lunan Pharma ......
  • 2017-2022 Europe Top Countries Cetirizine Hydrochloride Market Report
    Published: 21-Nov-2017        Price: US 4660 Onwards        Pages: 128
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Europe Cetirizine Hydrochloride market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Cetirizine Hydrochloride in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in Europe, focuses on the top players in each country, covering......
  • 2017-2022 Global Top Countries Cetirizine Hydrochloride Market Report
    Published: 21-Nov-2017        Price: US 4960 Onwards        Pages: 128
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the global Cetirizine Hydrochloride market size was xx million USD, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Cetirizine Hydrochloride in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle E......
  • Global Phenylketonuria (PKU) Market Professional Survey Report 2017
    Published: 21-Nov-2017        Price: US 3500 Onwards        Pages: 103
    This report studies Phenylketonuria (PKU) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Biomarin(US) - Vitaflo(UK) - Mead Johnson(US) - Nutricia(US)......
  • 2017-2022 India Cetirizine Hydrochloride Market Report (Status and Outlook)
    Published: 21-Nov-2017        Price: US 3360 Onwards        Pages: 128
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Cetirizine Hydrochloride market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In India market, the top players include - UCB Pharma - Pfizer - J & J - Mylan - Teva - HUAPONT Pharm - Hunan Jiudian Pharm - Sun Pharma - Lunan Pharm......
  • China Epinephrine Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022
    Published: 21-Nov-2017        Price: US 4480 Onwards        Pages: 118
    Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.......
  • 2017-2022 North America Cetirizine Hydrochloride Market Report
    Published: 21-Nov-2017        Price: US 4660 Onwards        Pages: 128
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the North America Cetirizine Hydrochloride market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Cetirizine Hydrochloride in North America market, especially in United States, Canada and Mexico, focuses on the top players in each country, covering - UCB Pharma - Pfizer......
  • 2017-2022 United States Cetirizine Hydrochloride Market Report (Status and Outlook)
    Published: 21-Nov-2017        Price: US 3360 Onwards        Pages: 128
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Cetirizine Hydrochloride market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In United States market, the top players include - UCB Pharma - Pfizer - J & J - Mylan - Teva - HUAPONT Pharm - Hunan Jiudian Pharm - Sun Pharma......
  • Global Cystic Fibrosis Drugs Market Professional Survey Report 2017
    Published: 21-Nov-2017        Price: US 3500 Onwards        Pages: 125
    This report studies Cystic Fibrosis Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Actavis - F. Hoffmann-La Roche - Gilead Sciences - Novartis......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs